Childhood obesity is associated with renal diseases. Maternal obesity is a risk factor linked to increased adipocytokines and metabolic disorders in the offspring. Therefore, we studied the impact of maternal obesity on renal-intrinsic insulin and adipocytokine signaling and on renal function and structure. To induce maternal obesity, female mice were fed a high-fat diet (HFD) or a standard diet (SD; control group) prior to mating, during gestation, and throughout lactation. A third group of dams was fed HFD only during lactation (HFD-Lac). After weaning at postnatal day (P)21, offspring of all groups received SD. Clinically, HFD offspring were overweight and insulin resistant at P21. Although no metabolic changes were detected at P70, renal sodium excretion was reduced by 40%, and renal matrix deposition increased in the HFD group. Mechanistically, two stages were differentiated. In the early stage (P21), compared with the control group, HFD showed threefold increased white adipose tissue, impaired glucose tolerance, hyperleptinemia, and hyperinsulinemia. Renal leptin/Stat3-signaling was activated. In contrast, the Akt/ AMPKa cascade and Krüppel-like factor 15 expression were decreased. In the late stage (P70), although no metabolic differences were detected in HFD when compared with the control group, leptin/Stat3-signaling was reduced, and Akt/AMPKa was activated in the kidneys. This effect was linked to an increase of proliferative (cyclinD1/D2) and profibrotic (ctgf/collagen IIIa1) markers, similar to leptin-deficient mice. HFD-Lac mice exhibited metabolic changes at P21 similar to HFD, but no other persistent changes. This study shows a link between maternal obesity and metabolic programming of renal structure and function and intrinsic-renal Stat3/Akt/AMPKa signaling in the offspring. (Endocrinology 158: 3399-3415, 2017) O besity has become a growing epidemic over the last two decades. Recent studies report that in the United States and Europe almost 50% of the population is overweight or obese (1). Of particular concern is the fact that more than 20% of children are obese (2), highlighting the growing global childhood obesity epidemic. The causes of obesity are multifactorial, including behavioral and nutritional factors, reduced physical activity, and genetic predisposition. Reports indicate that maternal obesity and rapid postnatal weight gain are risk
factors for obesity in infancy and beyond (3, 4) . For example, observational data have shown a link between maternal preconceptional weight, gestational weight gain, and offspring weight (5) . Moreover, maternal obesity and rapid postnatal weight gain do not only lead to overweight in the offspring but also appear to have long-term effects on their metabolism (6) . The process by which nutritional and metabolic influences during a critical window of development affect long-term organ structure and physiology is known as "metabolic programming" (7) .
Obesity and other characteristics of the metabolic syndrome have been recognized as major risk factors for renal diseases and are related to the rising prevalence of end-stage renal disease (8) and chronic kidney disease (CKD) not only in adults but also in children (9) . For example, in pediatric renal transplants, obese patients are at a higher risk for complications, cardiopulmonary disease, thrombosis, and death (10) . Moreover, there is a growing body of evidence that obesity causes renal injury and contributes to obesity-related CKD (11, 12) . Because onset of obesity-associated renal disease is asymptomatic, the need to unravel the underlying mechanisms for defining preventive strategies at an early stage is clear.
Adipose tissue is an active endocrine organ, secreting various hormones and adipocytokines. Notable among these is leptin. Leptin is intimately linked to insulin resistance (13, 14) and impaired glucose metabolism and thereby contributes to the pathogenesis of diabetic nephropathy. Adipocytokines and insulin are well recognized as inflammatory or proliferative triggers but also as key regulators of cell homeostasis and extracellular matrix (ECM) production as well as maintenance of electrolyte balance, making them mechanistically important in the pathogenesis of renal diseases (15) (16) (17) (18) . Because obesity has been identified as a strong risk factor for the development and progression of kidney disease, we queried whether maternal obesity during pregnancy and lactation does not only induce obesity in the offspring but also has adverse effects on renal development, structure, and function and ultimately leads to renal metabolic programming.
Here, we propose a two-stage animal disease model of renal dysfunction in the offspring of obese dams. In the early phase, early-onset obesity caused by maternal obesity during gestation and lactation is related to high levels of circulating leptin and insulin, impaired glucose metabolism, and activation of renal leptin signaling (Stat3); in contrast, AMPKa signaling and Krüppel-like factor 15 (klf15), which are important in cell differentiation, are markedly reduced. In the late phase (after resuming standard diet), the offspring of obese dams are not overweight and do not exhibit changes in glucose metabolism compared with the control group, yet they show features of leptin resistance and a marked activation of both renal Akt and AMPKa signaling. Moreover, maternal obesity leads to reduced sodium secretion and mild reduction of the glomerular filtration rate in the offspring at P70, increased renal weight, greater deposition of ECM, and upregulated expression of proliferative signaling molecules in the offspring. Similar changes were found in leptin-deficient (ob/ob) mice, indicating the important mechanistic role of leptin in renal metabolic programming. These findings emphasize the adverse impact of maternal obesity on renal metabolic programming in offspring, highlight the important role of leptin, and offer potential preventive targets.
Materials and Methods

Animal procedures
All animal procedures were performed in accordance with German regulations and legal requirements and were approved by the local government authorities (LANUV, NRW, Germany; AZ #2012A424, AZ #2011-025, and AZ #50.15.015). Virgin female mice (C57Bl/6N) from our own colony served as future dams and were housed in a room at 22 6 2°C and exposed to a 12-hour dark/light cycle. After weaning [postnatal day (P)21], they either received a high fat diet [HFD (HFD mat ; modified catalog no. C1057; Altromin, Lage, Germany)] for induction of obesity or a standard diet (SD) (Control mat ; ssniff catalog no. R/ M-H, V1534-0) for 8 to 10 weeks. HFD mat and Control mat dams were time-mated with SD-fed male mice and continued on their respective diets. At birth, some of the Control mat dams continued SD throughout lactation (Control), and some Control mat were switched to HFD from P1 to P21 [i.e., during lactation (HFD-Lac)]. After birth, the litter size of all dams was normalized to six for each litter. Water and chow were available ad libitum, and food was withdrawn only for experimental reasons. After weaning at P21, male offspring of the three groups were fed SD until P70. The three groups were defined as control (Control mat followed by SD during gestation and lactation), HFD-Lac (Control mat followed by SD during gestation and HFD during lactation), and HFD (HFD mat followed by HFD during gestation and lactation; also referred to as maternal obesity). The exact numbers of animals are listed in the figure legends. Because metabolism and the effect of maternal HFD differs between male and female offspring (19, 20) , we only included male mice in the experiments. This excludes sex differences and facilitates interpretation of the data. Nevertheless, further studies are required to address sex-specific differences in renal metabolic programming. The control and HFD-Lac protocols were established in previous respiratory studies (21) . ob/ob mice were raised under similar conditions in the Centre of Pharmacology, University Hospital of Cologne.
Physiological data of dams and offspring
Mice were time-mated, and female mice were checked the following morning for vaginal plugs. Body weight (grams) of dams was measured before mating [gestational day (G)1] and at weaning (P21). Offspring body and renal (right kidney) and epigonadal white adipose tissue (WAT) weights were obtained at different time points (P1, P7, P14, P21, and P70).
Leptin and insulin enzyme-linked immunosorbent assay
Measurements of murine serum leptin and insulin levels were performed using commercially available enzyme-linked immunosorbent assay (ELISA) systems (mouse leptin ELISA, ESML-82K, Millipore; mouse insulin ELISA, EZRMI.13K, Millipore, Darmstadt, Germany).
Intraperitoneal glucose tolerance test
Dams (Control  mat and HFD   mat , prior to mating) and offspring (at P21 and P70) underwent an intraperitoneal (IP) glucose tolerance test (GTT) as previously described (22) . In brief, animals were fasted overnight (16 hours). Fasting blood glucose levels were determined by tail vein blood sample collection, followed by IP injection of 20% glucose (10 mL/kg body weight). Blood glucose levels were measured using a glucometer (GlucoMen LX; A. Menarini Diagnostics, Berlin, Germany) after 15, 30, 60, and 120 minutes.
Metabolic studies and physiological parameters
Metabolic studies, including standardized analysis of renal function, were performed at P70. The animals were housed individually in a metabolic cage for 24 hours, allowing exact quantification of food and water intake as well as urine excretion as previously described (23) . Blood samples were obtained from the mandibular vein at the end of the experiment. Serum and urine electrolytes were analyzed with the automatic analyzer Integra 800 (Cobas 8000; Roche Diagnostics, Mannheim, Germany).
Tissue preparation
The kidneys and the epigonadal WAT were excised at P21 and P70. The right kidney and the WAT were immediately frozen in liquid nitrogen. The left kidney was fixed in 4% paraformaldehyde in phosphate-buffered saline for histology.
RNA extraction, real-time reverse transcription polymerase chain reaction Total RNA was isolated from renal tissue, and real-time reverse transcription polymerase chain reaction (RT-PCR) was performed as previously described using the 7500 Real-time PCR system (Applied Biosystems, Foster City, CA) (23) . The relative amounts of target messenger RNA (mRNA) were normalized to glyceraldehyde 3-phosphate dehydrogenase (GAPDH) or b-actin. Primers and Taq-Man probes are listed in Supplemental Table 1 .
Protein isolation and immunoblotting
Protein isolation and immunoblotting were performed as described previously (24 
Renal tissue immunostaining
Tissue preparation was performed as described previously (24) . Matrix and collagen deposition was assessed by Picro Sirius Red staining according to the manufacturer's protocol (Picro Sirius Red Stain kit; ScyTek Laboratories, Inc., Logan, UT).
Analysis of data
Gene expression was assessed by real-time RT-PCR, calculated based on the DDCt-method, and expressed as fold induction of mRNA expression. Housekeeping genes were used to normalize the genes of interest. Values are shown as means 6 standard error of the mean. Two-tailed Mann-Whitney test, one-way analysis of variance (ANOVA) followed by Dunn test, and two-way ANOVA followed by a Bonferroni post hoc test were used to test for statistical significance at the given time points. A P value ,0.05 was considered statistically significant. Densitometric analysis of protein bands was performed using ImageLab software (Bio-Rad, Munich, Germany). Band intensities from samples were normalized for loading using the b-actin band from the same sample.
Results
Clinical and renal histological phenotype
Maternal obesity induced by HFD leads to rapid postnatal weight gain with transient overweight at P21
To confirm that HFD induces obesity and disrupts glucose metabolism in dams, we measured body weight and assessed glucose tolerance by IP GTT 1 week before mating. We found that HFD for 8 to 10 weeks after weaning led to overweight compared with the control group (Fig. 1A) . This overweight was associated with an impaired glucose tolerance 15 and 30 minutes after glucose injection (Fig. 1B) . At birth, HFD offspring were significantly lighter but developed increased body weight at P21 when compared with control offspring (Fig. 1C) . After P21, HFD and control offspring were fed SD. Despite the overweight at P21, the HFD offspring displayed a significantly lower body weight compared with control offspring at P70 (Fig. 1D) . Measurement of right kidney weight did not show a difference between the groups at P1 and P21; at P70, however, kidneys of the HFD group were significantly heavier than those of the control group (Fig. 1E ). To summarize, maternal obesity induces accelerated postnatal weight gain with transient overweight during a critical window of renal development and increased renal weight at P70.
Maternal obesity leads to significant renal retention of sodium and to mild reduction of the glomerular filtration rate in the offspring at P70
To investigate if maternal obesity adversely affects long-term renal phenotypes, we analyzed the renal function of the offspring. At P70, we assessed food and water intake and obtained serum and urine from the offspring of both groups using metabolic cages for 24 hours. There were no significant differences in food consumption, water intake, or diuresis (data not shown). Analysis of urinary sodium and potassium excretion, however, revealed a marked reduction in sodium excretion ( Fig. 2A ), but not potassium excretion, in the HFD group (data not shown), indicating a higher sodium retention. Calculation of fractional sodium excretion showed similar results (Fig. 2B ). Serum potassium and sodium concentrations were similar in both groups (data not shown). Glomerular filtration rate was not significantly lower in the offspring of obese dams when compared with control mice (Fig. 2C ).
Maternal obesity induces profibrotic effects in the kidneys of offspring
To determine if maternal obesity induces fibrotic changes in the kidneys of offspring, we performed Sirius Red staining of renal tissue, which showed increased interstitial staining in the renal cortex of the HFD group at P70. Representative images of four animals per group are displayed in Fig. 3A . The histological finding of increased renal fibrosis after maternal obesity was supported by significantly increased gene expression of connective tissue growth factor (ctgf) (Fig. 3B ) and collagen IIIa1 (col IIIa1) (Fig. 3D) . In summary, maternal obesity induces long-term profibrotic expression pattern and increased matrix deposition in the kidney of the offspring. 
Analysis of early (P21) and late (P70) molecular mechanisms
Maternal obesity leads to increased epigonadal WAT and transient hyperleptinemia in offspring
We next assessed WAT and found that the HFD offspring had a threefold increase of epigonadal WAT at P21 (P , 0.001) when compared with the control mice (Fig. 4A) . Leptin mRNA expression in WAT was 15-fold greater (P , 0.001) (Fig. 4C ) and circulating leptin concentrations twofold higher (Fig. 4E) in the HFD group than in the control group at P21. At P70, the epigonadal WAT mass remained significantly greater in the HFD group compared with the control group (Fig. 4B) . Leptin mRNA expression in the epigonadal WAT and serum leptin concentrations were not different in the HFD group when compared with the control group at P70 (Fig. 4D  and 4F ). To conclude, maternal obesity is associated with a persistent increase in WAT mass and with a marked but transient elevation of circulating leptin concentration in the offspring at P21.
Maternal obesity induces transient impaired glucose tolerance with hyperinsulinemia at P21 and long-term activation of Akt signaling at P70 in offspring
Because leptin is strongly linked to impaired insulin sensitivity and glucose intolerance, we measured circulating insulin concentrations and found a fourfold increase in HFD offspring in comparison with control mice at P21 (Fig. 5A ). This hyperinsulinemia in the HFD group at P21 was coupled with increased fasting glucose levels (P , 0.05) and impaired glucose tolerance 15, 30, 60, and 120 minutes after IP injection of glucose, suggesting an insulin resistance in the HFD group at P21 (Fig. 5C) . Therefore, we assessed renal InsR and its intracellular Akt signaling. We found no significant changes compared with the control group ( Fig. 5E and 5G ). At P70, serum insulin concentrations and IP GTT were not different in HFD offspring and control mice ( Fig. 5B and 5D ). Although there was no difference in renal InsR protein expression (Fig. 5F ), Akt signaling was markedly activated in the kidneys of the HFD group (Fig. 5H ). To sum up, maternal obesity induces transient hyperinsulinemia and impairment of glucose tolerance in the offspring at P21; at P70, glucose metabolism is normalized, but Akt signaling is markedly increased in kidneys of the HFD group when compared with the control group.
Maternal obesity induces early-onset activation of leptin-Stat3-SOCS3 signaling at P21 and long-term reduction of leptin receptor as well as inhibition of Stat3 signaling at P70 Maternal obesity induces increased epigonadal WAT mass coupled with transient higher circulating leptin concentrations at P21 in offspring. Therefore, we next tested if intrinsic-renal leptin signaling is concomitantly activated. First, we measured mRNA expression of leptin in the kidney and found a more than fivefold induction in HFD offspring compared with control mice at P21 (Fig. 6A) . Renal leptin receptor protein expression remained unchanged (Fig. 6C) , but Stat3 activation was significantly increased in kidneys of the HFD offspring in comparison with control mice (Fig. 6E) . Leptin regulates expression of various targets; notable among those and well described in the literature are SOCS3 (upregulated by leptin) and neuropeptide y (NPY) (inhibited by leptin). Accordingly, we found a significant almost twofold increase of SOCS3 protein abundance by immunoblot (Fig. 6G) and a significant reduction of NPY mRNA by 50% (Fig. 6I) in the HFD group when compared with the control group at P21, indicating an activation of intrinsic-renal leptin signaling after maternal obesity. At P70, we did not detect changes in renal-intrinsic gene expression of leptin, SOCS3 protein abundance, or NPY mRNA expression (Fig. 6B, 6H, 6J) . However, both leptin receptor protein and Stat3 activation were reduced by 50% in the HFD , and 120 minutes after IP injection of 20% glucose (10 mL/kg body weight) (P21, control: n = 12, HFD: n = 11; P70, control: n = 3, HFD: n = 10). (E-H) Protein abundance of InsR in kidneys was assessed by immunoblot at (E) P21 and (F) P70. Analysis of the activated (phosphorylated) Akt (pAkt) and total Akt as an indicator of insulin signaling in the kidneys was performed by immunoblot at (G) P21 and (H) P70; pAkt and InsR are displayed relative to total Akt or b-actin, respectively. Densitometric analyses are shown below the respective immunoblots (control: n = 6; HFD: n = 6). Control group: black bars; HFD group: white bars. Mean 6 standard error of the mean; two-way ANOVA followed by a Bonferroni post hoc test; Mann-Whitney test. *P , 0.05; **P , 0.01; ***P , 0.001. n.s., not significant. Fig. 6D and 6F ). In summary, maternal obesity leads to a transient activation of the renal-intrinsic leptin signaling in the offspring at P21 and a long-term reduction of leptin receptor expression and its renalintrinsic signaling at P70.
group (
Maternal obesity induces a transient reduction of klf15: regulator of podocyte differentiation and cell proliferation at P21
Because leptin has been recognized as a proinflammatory, proproliferative, and profibrotic cytokine in kidney disease, we hypothesized that mechanisms inhibiting these processes are reduced after HFD. klf15 belongs to the family of Krüppel-like factors, which comprises various DNA-binding zinc finger transcription factors, key regulators in cell proliferation, and differentiation. Recently, klf15 has been identified to exert an antiproliferative function and to be involved in podocyte differentiation (25, 26) . We therefore assessed klf15 protein in kidneys by quantitative RT-PCR and immunoblot and found a significant reduction of renal klf15 gene expression and protein abundance in HFD offspring compared with control mice at P21 (Fig. 7A and 7C ). In contrast, at P70, no difference in klf15 expression between both groups was detectable ( Fig. 7B and 7D ). In summary, early-onset obesity with hyperleptinemia and hyperinsulinemia seems to have an inhibitory effect on klf15 expression.
Maternal obesity induces early postnatal inhibition but long-term activation of AMPKa signaling pathway in kidneys of offspring
Leptin signaling and diabetes inhibit AMPK signaling, which is known as a key sensor of metabolism and energy homeostasis and to be involved in key renal cell functions. Furthermore, AMPK affects sodium secretion in the collecting ducts (27) , inhibits inflammatory processes, regulates cell survival, and increases insulin sensitivity (28) (29) (30) . We therefore assessed AMPKa activation in kidneys of the offspring of obese dams and control mice and found a significant reduction of phosphorylated AMPKa at P21 (Fig. 8A) , whereas AMPKa signaling was markedly activated at P70 (Fig. 8B) . To conclude, increased leptin signaling and impaired glucose tolerance were related to reduced AMPKa signaling at P21. In contrast, renal-intrinsic leptin resistance, activation of insulin signaling, and reduced sodium excretion were associated with activation of AMPKa at P70.
Maternal obesity induces long-term proliferative effects in kidneys of offspring
We next queried if the preceding findings favor cell cycle activity and fibrosis at P70. We assessed the expression of markers of proliferation and senescence using quantitative RT-PCR. Gene expression of indicators of senescence, cyclin-dependent kinase inhibitor 1 (CDK1, p21), cyclin-dependent kinase inhibitor 1B (CDKN1B, p27), and the transcription factor e2f1 were significantly reduced after maternal obesity (Fig. 9A-9C ). In contrast, gene expression of the proproliferative markers cyclinD1 and cyclinD2 was higher in the HFD group than in the control group at P70 (Fig. 9D and 9E ). In summary, despite unaltered metabolic changes at P70, maternal obesity induces long-term proliferative expression pattern in the kidney of the offspring.
ob/ob mice show increased expression of klf15, proliferative markers, and fibrotic markers
To determine if leptin could be mechanistically linked to proliferative and fibrotic changes seen in kidneys of the offspring of obese dams, we analyzed gene expression in the kidneys of 8-to 12-week-old ob/ob mice using realtime RT-PCR. The gene expression of klf15 (cell differentiation and survival) and of ctgf (index for fibrotic process) was higher in kidneys of ob/ob mice when compared with wild-type mice (P , 0.05) (Fig. 10A and  10B ). Moreover, as observed after HFD, we found significantly increased expression of cyclin D1 (Fig. 10C ) and by trend of cyclin D2 (Fig. 10D) 
(proproliferative).
Maternal obesity, but not rapid postnatal weight gain through HFD during lactation, has a marked effect on expression of proliferative and fibrotic markers as well as on renal tubular function
To unravel the critical window of maternal obesityrelated metabolic programming, we introduced a third experimental group, HFD-Lac. The dams of this HFDLac group were exclusively exposed to HFD during lactation, starting at P1 and ending at P21. After weaning, the offspring received SD. Offspring of HFD-Lac and HFD mice exhibited a rapid postnatal weight gain and were significantly heavier than the control group at P21. Body weight of the HFD-Lac group at P70 was not different, whereas the HFD group was significantly lighter compared with the control (Fig. 11A) . The increase in body weight at P21 was accompanied by an impaired IP GTT in both the HFD-Lac and HFD groups. Offspring of the HFD-Lac group exhibited significant higher blood glucose levels after 15 and 30 minutes compared with the control group. Interestingly, comparison of HFD and HFD-Lac showed higher blood glucose levels in the HFD group during the late phase of the GTT, with a significant difference at 30 minutes (Fig. 11B) . Insulin in the HFD-Lac group was not increased compared with control group (Fig. 11C) . We next assessed mRNA expression of klf15 and p21 at the early phase (P21) and found that the expression of both was significantly decreased in the HFD group (P , 0.05) when compared with HFD-Lac and the control groups (Fig. 11D and 11E) . To compare the impact of maternal obesity (intrauterine and postnatal window) and isolated HFD feeding during lactation (postnatal window), we assessed key findings of the HFD group in the HFD-Lac group at P70. Gene expression of p21, a marker of cell senescence, and of cyclin D1, a marker of proliferation, was lower and higher, respectively, in the HFD group than in the control group. In contrast, there were no changes in the HFD-Lac group (Fig. 11F and 11G) . Moreover, mRNA expression of ctgf and col Ia1 (Fig. 11H  and 11I ) was significantly increased in the kidneys of HFD offspring compared with control group, whereas HFD-Lac was unaltered. Finally, intrauterine exposure to maternal obesity (intrauterine and postnatal window), but not HFD-Lac (postnatal window), induced a significant lower urinary sodium excretion at P70 (Fig. 11J) . In summary, maternal obesity (intrauterine and postnatal window), but not HFD-Lac (postnatal window), favors renal proliferative and fibrotic changes and leads to reduced urinary sodium excretion in the offspring at P70.
Discussion
This study identifies two phases of renal metabolic programming induced by maternal obesity. In the early phase (P21), in which early-onset obesity in the offspring of obese dams is linked to high levels of circulating adipocytokines, this early subacute inflammatory state with an activation of leptin signaling was linked to impaired glucose metabolism, hyperinsulinemia, and reduced klf15 and AMPKa signaling (Fig. 12A) . In the late phase (P70), although body weight and metabolic parameters were similar in both groups, the offspring of obese dams showed renal fibrotic changes, increased sodium retention coupled with features of leptin resistance, and activation of Akt and AMPKa signaling (Fig. 12B) . The results after maternal obesity coupled with postnatal HFD indicate a dynamic programming of renal metabolism with fibrotic features and impaired renal function.
Maternal obesity is a risk factor for structural and functional renal impairment in offspring
Our results support previous findings (31, 32) that maternal obesity coupled with HFD represents a major risk factor for the offspring to develop features of metabolic syndrome. Offspring of obese dams were exposed to exogenous metabolic influences (i.e., maternal obesity and HFD and intrinsic influences (i.e., their own overweight) during the postnatal phase. This early-onset obesity (P21) is accompanied by higher levels of serum leptin. Adipocytokines are increased in overweight children (33); they are also directly linked to insulin secretion and leptin/insulin resistance, resulting in impaired glucose tolerance, similar to the results seen in our study, and ultimately in Type 2 diabetes (13, 34-36 ). During the late phase at P70, however, the HFD offspring exhibited normalized circulating leptin and insulin concentrations and glucose metabolism. Despite dietary change after weaning and weight loss, the HFD group maintained greater epigonadal WAT mass than the control group at P70, indicating a persistent change of body composition. Clinical studies in adults indicate that weight loss is beneficial and reverses reduced renal function (37) (38) (39) . In those studies, however, weight loss is accompanied by reduced fat mass. Interestingly, in our study offspring of obese dams exhibit a tendency toward a lower glomerular filtration rate and a reduced urinary sodium excretion after weight loss, but with increased WAT. These findings suggest that the metabolic mechanisms affecting renal function are different in obese adults and in metabolic programming.
Obesity is intimately linked to CKD (9, 40) . Recent studies show that prenatal metabolic risk factors, such as maternal gestational diabetes mellitus and low birth weight, are related to renal injury in later life (41) . Moreover, animal studies show that early-onset overweight caused by litter size reduction impairs metabolism and renal structure (23, 42) . In contrast, we used a model of diet-induced obesity and additionally exposed the offspring to metabolic changes not only postnatally but also during gestation. Taking all these aspects into consideration, our model intends to closely mimic the environmental situation in overweight or obese human pregnancies, whereas animal models of litter size reduction represent a nutritive surplus. The nutrient composition and maternal metabolism in the different models could very well account for the different metabolic and renal outcomes.
Which are the molecular mechanisms of a two-phase renal injury after maternal obesity?
Our study shows an early phase with renal-intrinsic activation of leptin signaling. This subacute inflammatory state is coupled with hyperinsulinemia and impaired glucose metabolism. Particularly, insulin is not only a key regulator of glucose homeostasis but is also known to exert proliferative and ECM-remodeling effects (43) . Likewise, leptin promotes fibrotic processes and is therefore mechanistically important in renal disease (16) . Moreover, AMPKa signaling is a key regulator of energy homeostasis and has an impact on inflammation (28) . Interestingly, HFD and leptin inhibit AMPK, whereas weight loss activates AMPK and is thereby protective (44) (45) (46) (47) . In our study, we indeed link hyperleptinemia, hyperinsulinemia, and impaired glucose metabolism to reduced AMPKa activation. Furthermore, we identify a link between early-onset obesity as a result of maternal obesity and reduced renal klf15 during the early phase. klf15 is a transcription factor that is known to exert antifibrotic function (26) and to regulate cell proliferation and differentiation (48) . Indeed, leptin-deficient mice showed increased expression of renal klf15, indicating that leptin signaling regulates klf15 directly or indirectly via metabolic changes. To conclude, inhibition of AMPKa coupled with reduced klf15 due to activated leptin signaling during the early phase could impair renal maturation and favor fibrosis, thereby adversely affecting long-term renal function and structure.
In the late phase (adulthood), blunted leptin signaling was linked to activation of AMPKa and the Akt cascade. Interestingly, AMPKa is regulated by leptin and has been shown to enhance insulin sensitivity, which likely induces proliferative Akt signaling (45, 49) . Moreover, kidneys from the offspring of obese dams showed increased expression of CTGF coupled with a pronounced interstitial renal matrix. CTGF promotes fibrosis (50) and could contribute to a self-sustaining inflammatoryfibrotic process.
Clinically, reduced urinary sodium secretion is a sign of early-stage diabetic nephropathy and obesity-related hypertension (51, 52) . Chronic inflammatory processes and activation of the sympathetic nerve system by adipocytokines or insulin could affect renal tubular sodium retention and thereby contribute to the pathogenesis of hypertension and obesity-related CKD (53, 54) . On the one hand, insulin signaling is a direct enhancer of sodium reabsorption (55, 56) ; on the other hand, AMPK regulates sodium transport and ion transporters and stimulates renal sodium and water reabsorption (57, 58) . Indeed, we found a marked activation of Akt/AMPKa signaling in the later phase. Furthermore, obesity has been linked to the activation of the renin-angiotensinaldosterone system, which in turn could contribute to increased sodium reabsorption (59) . Finally, renal dysfunction after maternal obesity might also be related to an increase in ECM, which compresses the renal medulla (52) .
The intrauterine period is critical for metabolic programming of the kidneys
In contrast to humans, kidney development in mice is not completed at birth, representing an ideal model to study the effects of metabolism on prematurity. To define the critical window of metabolic programming, we next exposed lean dams to HFD-Lac. Even though both HFDLac and HFD exhibited early-onset obesity, maternal obesity (HFD group) exhibited aggravated blood glucose intolerance and higher serum insulin at P21 when compared with HFD-Lac. Moreover, the HFD, but not the HFD-Lac, offspring showed reduced urinary sodium secretion, increased expression of fibrotic markers, and gene expression favoring proliferation. These findings suggest that isolated HFD during lactation has different effects on the offspring's kidneys than maternal obesity. It has been shown that maternal obesity has adverse influences on the infant by affecting placental function and birth weight, possibly by circulating adipocytokines and insulin levels (60) . Whether the intrauterine period alone or coupled with a postnatal fat-enriched diet is critical for metabolic programming remains uncertain.
Here, we show that maternal obesity induces earlyonset obesity in the offspring with activation of proliferative and fibrotic pathways via leptin and insulin (early phase), which ultimately lead to renal metabolic programming (late phase). Initial evidence suggests that the intrauterine period is a critical window for renal metabolic programming. These results highlight the need to define preventive strategies to shield the fetus and newborn from the metabolic effects of obese mothers. 
